FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study

被引：0
|
作者：
Hu-Yang, Chunshao [1 ]
Perez-Fernandez, Virginia [2 ]
Andreu Rodriguez, Ada Luz [1 ]
Andujar Espinosa, Ruben [3 ,4 ]
Valverde-Molina, Jose [5 ]
机构：
[1] Hosp Gen Univ Los Arcos Mar Menor, Dept Neumol, Murcia, Spain
[2] Univ Murcia, Dept Ciencias Sociosanitarias, Murcia, Spain
[3] Hosp Univ Virgen Arrixaca, Dept Neumol, Murcia, Spain
[4] Univ Murcia, Ciencias Salud Med, Murcia, Spain
[5] Hosp Gen Univ Santa Lucia, Med Resp Pediat, Murcia, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2022年 / 58卷 / 05期
关键词：
SPIROMETRY;
D O I：
10.1016/j.arbres.2021.03.028
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：442 / 443
页数：2
相关论文
共 46 条
  • [21] Fev1/fev6 To Diagnose Airflow Obstruction: Comparisons With Computed Tomography And Morbidity Indices
    Bhatt, S. P.
    Il-Kim, Y.
    Wells, J. M.
    Bailey, W. C.
    Ramsdell, J. W.
    Foreman, M. G.
    Jensen, R. L.
    Stinson, D.
    Wilson, C. G.
    Lynch, D. A.
    Make, B. J.
    Dransfield, M. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [22] Forced expiratory volume in 1 second/forced expiratory volume in 6 seconds (FEV1/FEV6) is a suboptimal surrogate for FEV1/forced vital capacity (FEV1/FVC) in the spirometric diagnosis of airflow obstruction in a diverse urban population
    Fukunaga, M
    Kim, EJ
    Sundaram, SC
    Sullivan, J
    Friedmann, P
    Salzman, SH
    CHEST, 2005, 128 (04) : 172S - 172S
  • [23] FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age
    Roberts, Scott D.
    Farber, Mark O.
    Knox, Kenneth S.
    Phillips, Gary S.
    Bhatt, Nitin Y.
    Mastronarde, John G.
    Wood, Karen L.
    CHEST, 2006, 130 (01) : 200 - 206
  • [24] Characteristics of pediatric asthma patients with bronchodilator irreversible airflow obstruction (AD)
    Chiang, G
    Strunk, RC
    Bacharier, LB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S1 - S1
  • [25] Fluticasone Furoate, Alone Or In Combination With Vilanterol, Decreases The Rate Of Fev1 Decline In Patients With Moderate Airflow Obstruction: Summit Study
    Celli, B. R.
    Martinez, F. J.
    Anderson, J.
    Brook, R.
    Crim, C.
    Kilbride, S.
    Newby, D. E.
    Vestbo, J.
    Yates, J.
    Calverley, P. M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [26] COPD Phenotypes: Pulmonary Vascular Resistance/FEV1 Ratio, Normalizing Hemodynamics to Degree of Airflow Obstruction
    Robles, J. D. Rivera
    Ahmad, I.
    Pendlebury, D.
    Sakr, L.
    Van, A. P.
    Heresi, G. A.
    Mehta, J. P.
    Rahaghi, F. N.
    Rahaghi, F. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Residual Volume Reversibility Predicts Reversible Airflow Obstruction In Asthma Better Than Fev1 Reversibility
    Rashidian, A.
    Sazgar, S.
    Mejia, J. E.
    Tyner, T.
    Abejie, B.
    Jain, V. V.
    Vempilly, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
    Chen, Li-Fei
    Ho, Shu-Chuan
    Jao, Wen-Cing
    Sheng, Te-Feng
    Kuo, Han-Pin
    Wang, Chun-Hua
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over
    Rosa, F. W.
    Perez-Padilla, R.
    Camelier, A.
    Nascimento, O. A.
    Menezes, A. M. B.
    Jardim, J. R.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (12) : 1615 - 1621
  • [30] Cut-off value of FEV1/FEV6 to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
    Hwang, Yong Il
    Kim, Youlim
    Rhee, Chin Kook
    Kim, Deog Kyeom
    Park, Yong Bum
    Yoo, Kwang Ha
    Jung, Ki-Suck
    Lee, Chang Youl
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (03): : 629 - 635
12345